Linked Life Data

21617185

Source:http://linkedlifedata.com/resource/pubmed/id/21617185

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-5-27
pubmed:abstractText
Metreleptin has been efficacious in improving metabolic control in patients with lipodystrophy, but its efficacy has not been tested in obese patients with type 2 diabetes.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1939-327X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1647-56
pubmed:meshHeading
pubmed-meshheading:21617185-Adipocytes, pubmed-meshheading:21617185-Adult, pubmed-meshheading:21617185-Blotting, Western, pubmed-meshheading:21617185-Body Weight, pubmed-meshheading:21617185-Cells, Cultured, pubmed-meshheading:21617185-Diabetes Mellitus, Type 2, pubmed-meshheading:21617185-Double-Blind Method, pubmed-meshheading:21617185-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:21617185-Female, pubmed-meshheading:21617185-Hemoglobin A, Glycosylated, pubmed-meshheading:21617185-Humans, pubmed-meshheading:21617185-Immunohistochemistry, pubmed-meshheading:21617185-Leptin, pubmed-meshheading:21617185-Male, pubmed-meshheading:21617185-Middle Aged, pubmed-meshheading:21617185-Obesity, pubmed-meshheading:21617185-Phosphorylation, pubmed-meshheading:21617185-Receptors, Leptin, pubmed-meshheading:21617185-STAT3 Transcription Factor, pubmed-meshheading:21617185-Signal Transduction
pubmed:year
2011
pubmed:articleTitle
Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.
pubmed:affiliation
Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural